David Price

19.5k total citations · 1 hit paper
106 papers, 2.9k citations indexed

About

David Price is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, David Price has authored 106 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Epidemiology, 25 papers in Infectious Diseases and 16 papers in Surgery. Recurrent topics in David Price's work include HIV/AIDS Research and Interventions (12 papers), HIV, Drug Use, Sexual Risk (9 papers) and Syphilis Diagnosis and Treatment (4 papers). David Price is often cited by papers focused on HIV/AIDS Research and Interventions (12 papers), HIV, Drug Use, Sexual Risk (9 papers) and Syphilis Diagnosis and Treatment (4 papers). David Price collaborates with scholars based in United Kingdom, United States and Canada. David Price's co-authors include Brian P. Saunders, Alastair Forbes, Matthew D. Rutter, Michael A. Kamm, Christopher J.M. Williams, Ian Talbot, Kay H. Wilkinson, BA Fielding, Brendan Payne and Ingvar Bjarnason and has published in prestigious journals such as Nature Genetics, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

David Price

102 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis

2004 903 citations Matthew D. Rutter, Brian P. Saunders et al. Gastroenterology profile →

Peers

Countries citing papers authored by David Price

Since Specialization

Citations

This map shows the geographic impact of David Price's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Price with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Price more than expected).

Fields of papers citing papers by David Price

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Price. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Price. The network helps show where David Price may publish in the future.

Co-authorship network of co-authors of David Price

This figure shows the co-authorship network connecting the top 25 collaborators of David Price. A scholar is included among the top collaborators of David Price based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Price. David Price is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Autologous Fat Grafting in Hand Surgery: A Systematic Review 2025 ·Plastic & Reconstructive Surgery Global Open ·(unknown), (unknown), David Price, (unknown), (unknown), (unknown), (unknown), Brendan J. MacKay	0
2	Exploring the effects of community-based volunteering to support older adults on volunteers: A mixed methods study in Ontario, Canada 2025 ·Evaluation and Program Planning ·Jessica Gaber, (unknown), (unknown), (unknown), Larkin Lamarche, Housne Begum, (unknown), (unknown), Doug Oliver, David Price, Dee Mangin	0
3	Complex Hospital-Based Electronic Prescribing–Based Intervention to Support Antimicrobial Stewardship: Qualitative Study 2024 ·JMIR Formative Research ·Kathrin Cresswell, Susan Hinder, Aziz Sheikh, (unknown), David Price, (unknown), Sarah Pontefract, Jamie J. Coleman, Jillian Beggs, Antony Chuter, Ann Slee, Robin Williams	0
4	Oral step-down for Staphylococcus aureus bacteraemia: An opportunity for antimicrobial stewardship? 2022 ·Clinical Infection in Practice ·(unknown), Brendan Payne, David Price, Lucia Pareja-Cebrian, Ulrich Schwab	4
5	Utility of Routine Laboratory Biomarkers to Detect COVID-19: A Systematic Review and Meta-Analysis 2021 ·Viruses ·Jana Suklan, James Cheaveau, Sarah Hill, (unknown), Kile Green, (unknown), (unknown), (unknown), Ashleigh Kernohan, David Price, A. Joy Allen, Eoin Moloney, Sara Graziadio	4
6	Care pathway and prioritization of rapid testing for COVID-19 in UK hospitals: a qualitative evaluation 2021 ·BMC Health Services Research ·(unknown), (unknown), Kile Green, Patrick Kierkegaard, David Price, Richard Body, A. Joy Allen, Sara Graziadio, (unknown), (unknown)	8
7	The Coronavirus and the Economy 2020 ·RePEc: Research Papers in Economics ·Jacob J. Crouse, David Price, Rachel F. Rodgers, (unknown), (unknown)	2
8	The unholy trinity of human herpesvirus 8-associated malignancy in a person living with HIV-1 2018 ·AIDS ·C.J. Duncan, (unknown), Mark Bower, David Price	1
9	FOXFIRE-SIRFLOX-FOXFIRE global prospective randomised studies of first-line selective internal radiotherapy (SIRT) in patients with liver metastases from colorectal cancer: KRAS mutation and tumour site analysis 2017 ·Annals of Oncology ·Harpreet Wasan, Ricky A. Sharma, Volker Heinemann, Navesh Sharma, Julien Taı̈eb, Jens Ricke, Marc Peeters, Michael Findlay, Pradeep S. Virdee, Sharon Love, Joanna Moschandreas, Peter Dutton, Val Gebski, Alastair Gray, David Price, G. Bower, Amir Montazeri, Peter Gibbs, Guy van Hazel	9
10	MP29-02's advanced delivery system contributes to its efficacy in patients with moderate/severe seasonal allergic rhinitis 2015 ·Allergy* ·Claus Bachert, Giorgio Walter Canonica, Joaquim Mullol, David Price, Peter W. Hellings, Guy W. Scadding, Ullrich Munzel, (unknown)	3
11	Treatment preferences in patients with moderate-severe seasonal allergic rhinitis: findings of a discrete choice experiment 2012 ·Annals of Allergy Asthma & Immunology ·Sarah Acaster, Warner Carr, Phil Lieberman, Claus Bachert, David Price	7
12	Pancreatic exocrine insufficiency in HIV‐positive patients 2005 ·HIV Medicine ·David Price, (unknown), Edmund Ong, (unknown), (unknown), (unknown)	20
13	Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis breakdown → 2004 ·Gastroenterology ·Matthew D. Rutter, Brian P. Saunders, Kay H. Wilkinson, (unknown), (unknown), Michael A. Kamm, Christopher J.M. Williams, David Price, Ian Talbot, Alastair Forbes	903
14	A fatal case of sclerosing mesenteritis 2003 ·Digestive and Liver Disease ·(unknown), E. Ioachim, Michael Michail, David Price, Niki J. Agnantis, Angelos M. Kappas, Epameinondas V. Tsianos	13
15	IGF-I and IGF-binding protein-3 measurements on filter paper blood spots in children and adolescents on GH treatment: use in monitoring and as markers of growth performance 2003 ·European Journal of Endocrinology ·Urmi Das, (unknown), Javad Khosravi, J K Wales, Gary Butler, M S Kibirige, Anastasia Diamandi, J. A. Jones, Leena Patel, C. M. Hall, David Price, Peter Clayton	12
16	Small bowel adenocarcinoma presenting as a first manifestation of Crohn's disease: report of a case, and a literature review 2002 ·European Journal of Gastroenterology & Hepatology ·Dimitrios Christodoulou, A. Skopelitou, Konstantinos H. Katsanos, Christos Katsios, Niki J. Agnantis, David Price, Angelos M. Kappas, Epameinondas V. Tsianos	17
17	Acute biochemical effects of growth hormone treatment compared with conventional treatment in familial hypophosphataemic rickets 1996 ·Clinical Endocrinology ·Leena Patel, Peter Clayton, Caroline Brain, (unknown), G. M. Addison, David Price, M.Z. Mughal	14
18	Safety and Efficacy of Human Growth Hormone Treatment in Girls with Turner Syndrome 1993 ·Hormone Research ·David Price, Peter Clayton, (unknown), Caleb Roberts	11
19	Demography, auxology and response to recombinant human growth hormone treatment in girls with Turner's syndrome in the Kabi Pharmacia International Growth Study 1993 ·Acta Paediatrica ·David Price, Kerstin Albertsson‐Wikland, (unknown)	14
20	Metronidazole reduces intestinal inflammation and blood loss in non-steroidal anti-inflammatory drug induced enteropathy. 1992 ·Gut ·Ingvar Bjarnason, Jeremy Hayllar, Paul Smethurst, David Price, M Gumpel	148

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact